BioSpace News Archive

Digital dentistry, including CAD/CAM dentistry, is transforming every aspect of professional oral care in dentistry to date.

Enteral feeding is the delivery of nutrients directly into the digestive tract through a feeding tube.

It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease.

SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), has released data on the performance of the Morphometric Imaging (MI) assay of the DISCERN test at the Alzheimer’s Association International Conference (AAIC), July 31 – Aug. 4, 2022, San Diego.

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2022 financial results after the close of market on Monday, August 8, 2022.

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the preprint in ResearchGate of a case study entitled “Tollovid as a Rescue Agent for Paxlovid Rebound in Acute COVID-19”.

OriCell Therapeutics (Shanghai) Co., Ltd. (“OriCell” or “the Company”) has announced the completion of Series B financing totaling over US$120 million.

Tavanta Therapeutics, today announced the completion of patient enrollment in the Company’s pivotal Phase 3 study for TAVT-45 (abiraterone acetate) Granules for Oral Suspension (“TAVT-45").

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced that it has been approved for nearly $7 million from the Patient-Centered Outcomes Research Institute to study how physical activity affects older adults undergoing lung cancer surgery.

Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced clearance by the Food and Drug Administration of its previously disclosed 510 submission and resumption of Tablo® Hemodialysis System shipments for home use.